Tau oligomers impair memory and synaptic plasticity through the cellular prion protein

Deposition of abnormally phosphorylated tau aggregates is a central event leading to neuronal dysfunction and death in Alzheimer's disease (AD) and other tauopathies. Among tau aggregates, oligomers (TauOs) are considered the most toxic. AD brains show significant increase in TauOs compared to healthy controls, their concentration correlating with the severity of cognitive deficits and disease progression. In vitro and in vivo neuronal TauO exposure leads to synaptic and cognitive dysfunction, but their mechanisms of action are unclear. Evidence suggests that the cellular prion protein (PrP<sup>C</sup>) may act as a mediator of TauO neurotoxicity, as previously proposed for β-amyloid and α-synuclein oligomers. To investigate whether PrP<sup>C</sup> mediates TauO detrimental activities, we compared their effects on memory and synaptic plasticity in wild type (WT) and PrP<sup>C</sup> knockout (Prnp<sup>0/0</sup>) mice. Intracerebroventricular injection of TauOs significantly impaired recognition memory in WT but not in Prnp<sup>0/0</sup> mice. Similarly, TauOs inhibited long-term potentiation in acute hippocampal slices from WT but not Prnp<sup>0/0</sup> mice. Surface plasmon resonance indicated a high-affinity binding between TauOs and PrP<sup>C</sup> with a K<sub>D</sub> of 20-50 nM. Immunofluorescence analysis of naïve and PrP<sup>C</sup>-overexpressing HEK293 cells exposed to TauOs showed a PrP<sup>C</sup> dose-dependent association of TauOs with cells over time, and their co-localization with PrP<sup>C</sup> on the plasma membrane and in intracellular compartments, suggesting PrP<sup>C</sup>-may play a role in TauO internalization. These findings support the concept that PrP<sup>C</sup> mediates the detrimental activities of TauOs through a direct interaction, suggesting that targeting this interaction might be a promising therapeutic strategy for AD and other tauopathies.

Authors

Institutions

Publication Details

Journal
Acta Neuropathologica Communications
Published
2025-01-27
DOI
https://doi.org/10.1186/s40478-025-01930-3
Citations
8
Primary Topic
Prion Diseases and Protein Misfolding
Type
article
Field-Weighted Citation Impact
6.45

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tau oligomers impair memory and synaptic plasticity through the cellular prion protein

Giovanna Musco, Antonio Masone, Marco Gobbi, Laura Colombo et al.
8 citations
Acta Neuropathologica Communications
Prion Diseases and Protein Misfolding
6.45
article

Tau oligomers impair memory and synaptic plasticity through the cellular prion protein

Giovanna Musco, Antonio Masone, Marco Gobbi, Laura Colombo, Roberto Chiesa, Nicholas M. Kanaan, Marten Beeg, Claudia Balducci, Susanna Leva, Milica Cerovic, Po-Tao Y. Chen, Luana Fioriti, Chiara Zucchelli, Franca Orsini, Ilaria Raimondi, Letizia Dacomo, Gianluigi Forloni, Giada Lavigna, Beatrice Rocutto, Eleonora Busani
article en
8 citations

Abstract

Deposition of abnormally phosphorylated tau aggregates is a central event leading to neuronal dysfunction and death in Alzheimer's disease (AD) and other tauopathies. Among tau aggregates, oligomers (TauOs) are considered the most toxic. AD brains show significant increase in TauOs compared to healthy controls, their concentration correlating with the severity of cognitive deficits and disease progression. In vitro and in vivo neuronal TauO exposure leads to synaptic and cognitive dysfunction, but their mechanisms of action are unclear. Evidence suggests that the cellular prion protein (PrP<sup>C</sup>) may act as a mediator of TauO neurotoxicity, as previously proposed for β-amyloid and α-synuclein oligomers. To investigate whether PrP<sup>C</sup> mediates TauO detrimental activities, we compared their effects on memory and synaptic plasticity in wild type (WT) and PrP<sup>C</sup> knockout (Prnp<sup>0/0</sup>) mice. Intracerebroventricular injection of TauOs significantly impaired recognition memory in WT but not in Prnp<sup>0/0</sup> mice. Similarly, TauOs inhibited long-term potentiation in acute hippocampal slices from WT but not Prnp<sup>0/0</sup> mice. Surface plasmon resonance indicated a high-affinity binding between TauOs and PrP<sup>C</sup> with a K<sub>D</sub> of 20-50 nM. Immunofluorescence analysis of naïve and PrP<sup>C</sup>-overexpressing HEK293 cells exposed to TauOs showed a PrP<sup>C</sup> dose-dependent association of TauOs with cells over time, and their co-localization with PrP<sup>C</sup> on the plasma membrane and in intracellular compartments, suggesting PrP<sup>C</sup>-may play a role in TauO internalization. These findings support the concept that PrP<sup>C</sup> mediates the detrimental activities of TauOs through a direct interaction, suggesting that targeting this interaction might be a promising therapeutic strategy for AD and other tauopathies.

Acta Neuropathologica CommunicationsVol. 13(1)
Neurosciences Institute (US), Mario Negri Institute for Pharmacological Research (IT), IRCCS Ospedale San Raffaele (IT), Columbia University (US), Michigan State University (US)
Alzheimer's Association, Fondazione Telethon, Ministero della Salute, National Institutes of Health
Openalex Percentile: Top 4%
Prion Diseases and Protein Misfolding
6.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.